Toxóide tetânico, Antigeno polisacarido meningococo grupo c

NEISVAC-C 0,5 ml SUSPENSIÓN INYECTABLE EN JERINGA PRECARGADA

10-20 µg + 10 µg suspensión inyectable en jeringa precargadaSpainMarketedAuthorised 22 Jul 2001

Packs

Pack	Code	Status
NEISVAC-C 0,5 ml SUSPENSIÓN INYECTABLE EN JERINGA PRECARGADA , 10 jeringas precargadas de 0,5 ml	632141
NEISVAC-C 0,5 ml SUSPENSIÓN INYECTABLE EN JERINGA PRECARGADA , 1 jeringa precargada de 0,5 ml	933788

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Toxóide tetânico, Antigeno polisacarido meningococo grupo c

NEISVAC-C 0,5 ml SUSPENSIÓN INYECTABLE EN JERINGA PRECARGADA

10-20 µg + 10 µg suspensión inyectable en jeringa precargadaSpainMarketedAuthorised 22 Jul 2001

Product informationAsk Osler about it

Packs

Pack	Code	Status
NEISVAC-C 0,5 ml SUSPENSIÓN INYECTABLE EN JERINGA PRECARGADA , 10 jeringas precargadas de 0,5 ml	632141
NEISVAC-C 0,5 ml SUSPENSIÓN INYECTABLE EN JERINGA PRECARGADA , 1 jeringa precargada de 0,5 ml	933788

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Toxóide tetânico, Antigeno polisacarido meningococo grupo c
Strength: 10-20 µg + 10 µg
Dosage form: suspensión inyectable en jeringa precargada
Route: vía intramuscular
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 22 Jul 2001
Registration: 64096
Marketing authorisation holder: Pfizer S.L.
Procedure: National, MRP or DCP
Supply: Diagnóstico Hospitalario